About: Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1993 (uk) im Januar 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1993 (ast) artikull shkencor i botuar më 01 janar 1993 (sq) scientific article published on 01 January 1993 (en)
publication date	wds:Q72655222-16698136-1351-4EFB-8939-7A10BE66237B
publication date	1993-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q72655222-427D998D-889B-4CBC-BE29-0D8E217CDB15 wds:Q72655222-6A4AE3D8-6D6E-4B6B-ACC0-1EE78DDE6AF1 wds:Q72655222-91A9F496-9A02-4C63-8024-4441638690BD wds:Q72655222-97ABCDC8-8703-4904-8104-9EFCD36690AF wds:Q72655222-BA08879B-A474-447B-A9AA-27E90DC659E2 wds:Q72655222-F00C0824-6E87-4D6D-B26D-714A91F0AA9D
author name string	H Kirchner H Poliwoda J Atzpodien M Deckert M Fenner E L Hänninen
rdfs:label	Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (en) Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (nl) Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (sq)
skos:prefLabel	Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (en) Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (nl) Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (sq)
name	Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (en) Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (nl) Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (sq)
title	wds:Q72655222-B185A955-AC86-4EDC-A793-372424C2CCC1
title	Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer (en)
page(s)	wds:Q72655222-2F0C45B9-C504-49B6-9E74-145D6B269840
page(s)	S6-8
instance of	wds:Q72655222-BDCD35B7-210D-48D5-86E3-65D58F5169CF
instance of	scholarly article
main subject	wds:Q72655222-1F4350A6-91A9-4EC4-BAAE-BBF847A0D231
main subject	wd:Q238512
PubMed ID	wds:Q72655222-0B4EB72A-AC35-49DD-BC3D-3CD1F4665712
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8260264
PubMed ID	8260264
published in	wds:Q72655222-B8086855-0F2B-4ED7-986D-FDB4AC384295
published in	European Journal of Cancer
volume	wds:Q72655222-33B33363-D685-48F5-AFFE-9129F7BDEBD2
volume	29A Suppl 5
DOI	wds:Q72655222-1470F3CD-D436-4F60-8BD5-CBAC149618F7
DOI	http://dx.doi.org/10.1016/0959-8049(93)90617-O
DOI	10.1016/0959-8049(93)90617-O
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72655222
is cites work of	Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma Renal cell carcinoma Renal cell carcinoma Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA. Enhanced therapeutic effects of anti-tumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party The biological treatment of renal-cell carcinoma and melanoma Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil Update on the application of interleukin-2 in the treatment of renal cell carcinoma Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel. [Intratesticular metastasis of renal cancer] Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value. Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trials Evolving immunotherapeutic strategies in bladder and renal cancer A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study Gene expression profiling of the synergy of 5-aza-2'-deoxycytidine and paclitaxel against renal cell carcinoma Biological response modifiers in cancer Prognostic value of the immunomonitoring of patients with renal cell carcinoma under therapy with IL-2/IFN-alpha-2 in combination with 5-FU Autologous immune enhancement therapy: A case report of a stage IV colonic cancer A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancer Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma? Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma Autologous renal cell cancer vaccines using heat shock protein-peptide complexes Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma Local interleukin-2 and interleukin-12 therapy of bovine ocular squamous cell carcinomas
is cites work of	wds:Q34549056-74D8BBEC-11F3-47BB-AA16-EA7A630BD9B8 wds:Q36641423-3855FFDE-66DC-428D-BBA1-03011488187D wds:Q36718958-57797E00-DBAA-46EF-BEB7-9FC27B957CC1 wds:Q54191734-F0E584B1-6B93-4F6C-867F-6D26B63CDCA6 wds:Q80605228-3171D8C1-8C65-4C45-8F89-BE320E3901F3 wds:Q34569970-14451AA0-7910-4D98-AF56-74ED2F167A23 wds:Q40786097-C9A75604-17B3-4A00-AA48-D4D682A7E0CA wds:Q34579246-3DA113E5-F566-420A-AC3C-A39E5373045C wds:Q35519671-597D8602-9295-41D8-A97C-511112CE318D wds:Q36621976-2EF2AC8C-43E8-4C8C-9019-02504C8A1C59 wds:Q46961534-5ACEFE14-8820-40C1-8528-3C3B84136377 wds:Q81154228-B186AECF-3070-4053-AA54-3EC054EA6178 wds:Q33745827-298E9848-914B-4C48-9612-76073C4CB5B9 wds:Q36348109-2B7B49E9-64B9-469E-818C-033A2F3B55DB wds:Q36589861-9F9C2988-28CB-432F-868B-68771E4308BB wds:Q35022491-4BDA06EC-7B89-4E17-A69A-BC4513C01494 wds:Q73669457-313BDBC0-E024-4906-AC96-33E35BD29388 wds:Q71466239-45F3959D-6101-4C28-AA46-4EE5268DCCE5 wds:Q79396495-0B3A89D0-76A2-4A88-AFB5-797201C33BF7 wds:Q36919283-97C25A39-5B92-46FE-A675-3AEACECCA696 wds:Q40685230-CF99C0D1-5B2B-4712-8B28-5491F4EA5B99

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software